BioSpace News Archive

Investment will accelerate product development and innovation for the behavioral health industry

Today, the U.S. Food and Drug Administration issued a proposed rule to set forth requirements related to the content, format and FDA’s review and communications procedures for premarket tobacco product applications (PMTAs) as part of the agency’s continued commitment to its oversight of e-cigarettes and other tobacco products.

Today, Swedish Medical Center, UCHealth Medical Center of the Rockies, Aspen Valley Hospital, Arkansas Valley Regional Medical Center and Parker Adventist Hospital were recognized with 2019 Ending the Wait awards for their outstanding achievements in facilitating the gift of life through organ and tissue donation in Colorado.

Newron Pharmaceuticals S.pA. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, is pleased to note its partner Meiji Seika Pharma Co., Ltd., together with Eisai Co., Ltd., have announced the manufacturing and marketing approval in Japan for Equfina® TABLETS

CStone Pharmaceuticals (“CStone” or the “Company”, HKEX: 2616) today released the preliminary data from the Phase I bridging study of the Company’s investigational anti-PD-1 monoclonal antibody CS1003 for the first time, in an oral presentation at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO, 2019 CSCO Annual Meeting).

Yesse Technologies, Inc. (formerly MouSensor), a New York-headquartered biotechnology company, has been awarded a $750,000 National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant.

Thomas Jefferson University will officially mark the opening of the College of Health Professions Physician Assistant Program in Voorhees, NJ.

Ipsen (Euronext: IPN; ADR: IPSEY) today presents results from the matching-adjusted indirect comparison (MAIC) of cabozantinib (Cabometyx®) versus regorafenib (Stivarga®) for the second-line treatment (2L) of patients with advanced hepatocellular carcinoma (aHCC) who received sorafenib as the only prior systemic therapy.

UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people who may be affected by severe weather and flooding across parts of Texas.

The Sandra Atlas Bass Heart Hospital at North Shore University Hospital (NSUH) has achieved three-star overall quality ratings – the highest possible ranking – in all five cardiac surgical categories analyzed by the Society of Thoracic Surgeons (STS)